A citation-based method for searching scientific literature

Jing Shen, Mary Beth Terry, Yuyan Liao, Irina Gurvich, Qiao Wang, Ruby T Senie, Regina M Santella. PLoS One 2012
Times Cited: 8







List of co-cited articles
29 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Telomere measurement by quantitative PCR.
Richard M Cawthon. Nucleic Acids Res 2002
37

A prospective study of relative telomere length and postmenopausal breast cancer risk.
Immaculata De Vivo, Jennifer Prescott, Jason Y Y Wong, Peter Kraft, Susan E Hankinson, David J Hunter. Cancer Epidemiol Biomarkers Prev 2009
101
37

Telomere length in peripheral blood and breast cancer risk in a prospective case-cohort analysis: results from the Sister Study.
Sangmi Kim, Dale P Sandler, Gleta Carswell, Lisa A De Roo, Christine G Parks, Richard Cawthon, Clarice R Weinberg, Jack A Taylor. Cancer Causes Control 2011
33
37

Multiple genetic variants in telomere pathway genes and breast cancer risk.
Jing Shen, Marilie D Gammon, Hui-Chen Wu, Mary Beth Terry, Qiao Wang, Patrick T Bradshaw, Susan L Teitelbaum, Alfred I Neugut, Regina M Santella. Cancer Epidemiol Biomarkers Prev 2010
41
37

The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer.
Esther M John, John L Hopper, Jeanne C Beck, Julia A Knight, Susan L Neuhausen, Ruby T Senie, Argyrios Ziogas, Irene L Andrulis, Hoda Anton-Culver, Norman Boyd,[...]. Breast Cancer Res 2004
232
25

Global DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry.
Lissette Delgado-Cruzata, Hui-Chen Wu, Mary Perrin, Yuyan Liao, Maya A Kappil, Jennifer S Ferris, Julie D Flom, Hulya Yazici, Regina M Santella, Mary Beth Terry. Epigenetics 2012
33
25

Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant for breast cancer from the New York site of the BCFR.
Nicola Machella, Mary Beth Terry, Jennifer Zipprich, Irina Gurvich, Yuyan Liao, Ruby T Senie, David O Kennedy, Regina M Santella. Carcinogenesis 2008
28
25

Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry.
Hui-Chen Wu, Lissette Delgado-Cruzata, Julie D Flom, Mary Perrin, Yuyan Liao, Jennifer S Ferris, Regina M Santella, Mary Beth Terry. Carcinogenesis 2012
52
25

DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer.
David O Kennedy, Meenakshi Agrawal, Jing Shen, Mary Beth Terry, Fang Fang Zhang, Ruby T Senie, Grazyna Motykiewicz, Regina M Santella. J Natl Cancer Inst 2005
75
25

Short telomere length and breast cancer risk: a study in sister sets.
Jing Shen, Mary Beth Terry, Irina Gurvich, Yuyan Liao, Ruby T Senie, Regina M Santella. Cancer Res 2007
113
25

Plasma protein carbonyls and breast cancer risk in sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry.
Jennifer Zipprich, Mary Beth Terry, Yuyan Liao, Meenakshi Agrawal, Irina Gurvich, Ruby Senie, Regina M Santella. Cancer Res 2009
24
25


Comparison of chromosome telomere integrity in multiple tissues from subjects at different ages.
M G Butler, J Tilburt, A DeVries, B Muralidhar, G Aue, L Hedges, J Atkinson, H Schwartz. Cancer Genet Cytogenet 1998
84
25


Telomere length, current perceived stress, and urinary stress hormones in women.
Christine G Parks, Diane B Miller, Erin C McCanlies, Richard M Cawthon, Michael E Andrew, Lisa A DeRoo, Dale P Sandler. Cancer Epidemiol Biomarkers Prev 2009
126
25

Estrogen activates telomerase.
S Kyo, M Takakura, T Kanaya, W Zhuo, K Fujimoto, Y Nishio, A Orimo, M Inoue. Cancer Res 1999
390
25

Effect of long-term hormone therapy on telomere length in postmenopausal women.
Duk-Chul Lee, Jee-Aee Im, Jeong-Ho Kim, Hye-Ree Lee, Jae-Yong Shim. Yonsei Med J 2005
81
25

Mechanism of telomere shortening by oxidative stress.
Shosuke Kawanishi, Shinji Oikawa. Ann N Y Acad Sci 2004
303
25

Sex difference in leukocyte telomere length is ablated in opposite-sex co-twins.
Athanase Benetos, Christine Dalgård, Carlos Labat, Jeremy D Kark, Simon Verhulst, Kaare Christensen, Masayuki Kimura, Kent Horvath, Kirsten Ohm Kyvik, Abraham Aviv. Int J Epidemiol 2014
25
25



The association of telomere length and cancer: a meta-analysis.
Ingrid M Wentzensen, Lisa Mirabello, Ruth M Pfeiffer, Sharon A Savage. Cancer Epidemiol Biomarkers Prev 2011
322
25

Longer telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China.
Qing Lan, Richard Cawthon, Yutang Gao, Wei Hu, H Dean Hosgood, Francesco Barone-Adesi, Bu-Tian Ji, Bryan Bassig, Wong-Ho Chow, Xiaoou Shu,[...]. PLoS One 2013
87
25

Identification of seven loci affecting mean telomere length and their association with disease.
Veryan Codd, Christopher P Nelson, Eva Albrecht, Massimo Mangino, Joris Deelen, Jessica L Buxton, Jouke Jan Hottenga, Krista Fischer, Tõnu Esko, Ida Surakka,[...]. Nat Genet 2013
564
25

Genetic variation in five genes important in telomere biology and risk for breast cancer.
S A Savage, S J Chanock, J Lissowska, L A Brinton, D Richesson, B Peplonska, A Bardin-Mikolajczak, W Zatonski, N Szeszenia-Dabrowska, M Garcia-Closas. Br J Cancer 2007
64
25

Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers.
Jonathan Beesley, Hilda A Pickett, Sharon E Johnatty, Alison M Dunning, Xiaoqing Chen, Jun Li, Kyriaki Michailidou, Yi Lu, David N Rider, Rachel T Palmieri,[...]. PLoS One 2011
40
25

Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study.
Andrew J Pellatt, Roger K Wolff, Gabriela Torres-Mejia, Esther M John, Jennifer S Herrick, Abbie Lundgreen, Kathy B Baumgartner, Anna R Giuliano, Lisa M Hines, Laura Fejerman,[...]. Genes Chromosomes Cancer 2013
65
25

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
Stig E Bojesen, Karen A Pooley, Sharon E Johnatty, Jonathan Beesley, Kyriaki Michailidou, Jonathan P Tyrer, Stacey L Edwards, Hilda A Pickett, Howard C Shen, Chanel E Smart,[...]. Nat Genet 2013
385
25

Employment and work schedule are related to telomere length in women.
C G Parks, L A DeRoo, D B Miller, E C McCanlies, R M Cawthon, D P Sandler. Occup Environ Med 2011
35
25

Tubal sterilization trends in the United States.
Lolita M Chan, Carolyn L Westhoff. Fertil Steril 2010
91
12

Hereditary ovarian cancer.
Antonio Russo, Valentina Calò, Loredana Bruno, Sergio Rizzo, Viviana Bazan, Gaetana Di Fede. Crit Rev Oncol Hematol 2009
77
12

Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland.
Jacek Gronwald, Tomasz Byrski, Tomasz Huzarski, Cezary Cybulski, Ping Sun, Anna Tulman, Steven A Narod, Jan Lubinski. Breast Cancer Res Treat 2006
63
12

The distal fallopian tube: a new model for pelvic serous carcinogenesis.
Christopher P Crum, Ronny Drapkin, Alexander Miron, Tan A Ince, Michael Muto, David W Kindelberger, Yonghee Lee. Curr Opin Obstet Gynecol 2007
324
12

Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations.
A S Whittemore, R R Balise, P D P Pharoah, R A Dicioccio, I Oakley-Girvan, S J Ramus, M Daly, M B Usinowicz, K Garlinghouse-Jones, B A J Ponder,[...]. Br J Cancer 2004
82
12

Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis.
David Cibula, Michal Zikan, Ladislav Dusek, Ondrej Majek. Expert Rev Anticancer Ther 2011
51
12

The fallopian tube: primary site of most pelvic high-grade serous carcinomas.
Shannon Salvador, Blake Gilks, Martin Köbel, David Huntsman, Barry Rosen, Dianne Miller. Int J Gynecol Cancer 2009
124
12

Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.
John R McLaughlin, Harvey A Risch, Jan Lubinski, Pal Moller, Parviz Ghadirian, Henry Lynch, Beth Karlan, David Fishman, Barry Rosen, Susan L Neuhausen,[...]. Lancet Oncol 2007
140
12

Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study.
Antonis C Antoniou, Matti Rookus, Nadine Andrieu, Richard Brohet, Jenny Chang-Claude, Susan Peock, Margaret Cook, D Gareth Evans, Rosalind Eeles, Catherine Nogues,[...]. Cancer Epidemiol Biomarkers Prev 2009
92
12


No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages <50 years.
Valerie McGuire, Esther M John, Anna Felberg, Robert W Haile, Norman F Boyd, Duncan C Thomas, Mark A Jenkins, Roger L Milne, Mary B Daly, John Ward,[...]. Cancer Epidemiol Biomarkers Prev 2006
22
12

Alcohol Intake and Breast Cancer Risk: Weighing the Overall Evidence.
Jasmine A McDonald, Abhishek Goyal, Mary Beth Terry. Curr Breast Cancer Rep 2013
37
12

Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.
Welmoed Reitsma, Geertruida H de Bock, Jan C Oosterwijk, Joost Bart, Harry Hollema, Marian J E Mourits. Eur J Cancer 2013
72
12

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.
S A Narod, H Risch, R Moslehi, A Dørum, S Neuhausen, H Olsson, D Provencher, P Radice, G Evans, S Bishop,[...]. N Engl J Med 1998
384
12

Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.
V McGuire, A Felberg, M Mills, K L Ostrow, R DiCioccio, E M John, D W West, A S Whittemore. Am J Epidemiol 2004
93
12

Parity, contraception, infertility, and the risk of epithelial ovarian cancer.
H A Risch, L D Marrett, G R Howe. Am J Epidemiol 1994
174
12

Pooled analysis of 3 European case-control studies: I. Reproductive factors and risk of epithelial ovarian cancer.
E Negri, S Franceschi, A Tzonou, M Booth, C La Vecchia, F Parazzini, V Beral, P Boyle, D Trichopoulos. Int J Cancer 1991
125
12

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S Buys, Edward Partridge, Amanda Black, Christine C Johnson, Lois Lamerato, Claudine Isaacs, Douglas J Reding, Robert T Greenlee, Lance A Yokochi, Bruce Kessel,[...]. JAMA 2011
710
12

Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives.
I B Runnebaum, S Wang-Gohrke, D Vesprini, R Kreienberg, H Lynch, R Moslehi, P Ghadirian, B Weber, A K Godwin, H Risch,[...]. Pharmacogenetics 2001
32
12


BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research.
Susan L Neuhausen, Hilmi Ozcelik, Melissa C Southey, Esther M John, Andrew K Godwin, Wendy Chung, Jeniffer Iriondo-Perez, Alexander Miron, Regina M Santella, Alice Whittemore,[...]. Breast Cancer Res Treat 2009
46
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.